Choque vasopléjico en cirugía cardíaca: el rol de azul de metileno desde la farmacología clínica. Artículo de revisión

Liu, 2017, Vasoplegic syndrome: An update on perioperative considerations, J Clin Anesth., 40, 63, 10.1016/j.jclinane.2017.04.017 Ortega, 2018, Síndrome vasopléjico en cirugía cardíaca, Rev Perfus Colomb., 1, 18 Aguirre-Sánchez, 2011, Síndrome vasopléjico, Arch Cardiol Mex., 81, 58 Shaefi, 2018, Vasoplegia after cardiovascular procedures—pathophysiology and targeted therapy, J Cardiothorac Vasc Anesth., 32, 1013, 10.1053/j.jvca.2017.10.032 Vincent, 2013, Circulatory shock, N Engl J Med., 369, 1726, 10.1056/NEJMra1208943 Omar, 2015, Cardiac vasoplegia syndrome: Pathophysiology. Risk factors and treatment, Am J Med Sci., 349, 80, 10.1097/MAJ.0000000000000341 Fischer, 2010, Vasoplegia during cardiac surgery: Current concepts and management, Semin Thorac Cardiovasc Surg., 22, 140, 10.1053/j.semtcvs.2010.09.007 Moncada, 1991, Endogenous nitric oxide: Physiology, pathology and clinical relevance, Eur J Clin Invest., 21, 361, 10.1111/j.1365-2362.1991.tb01383.x Lambden, 2018, Definitions and pathophysiology of vasoplegic shock, Crit Care [Internet]., 22 Hazarika, 2015, Vasoplegic syndrome: A challenge to anaesthetic management, J Neuroanaesth Crit Care., 02, 139, 10.4103/2348-0548.155467 Gülmen, 2011, A complex situation in cardiac surgery: Vasoplegic syndrome, Anatol J Clin Investig., 5, 65 Ulusoy, 2008, The concentration-dependent contractile effect of methylene blue in the human internal mammary artery: A quantitative approach to its use in the vasoplegic syndrome, J Cardiothorac Vasc Anesth., 22, 560, 10.1053/j.jvca.2008.02.018 Mekontso-Dessap, 2001, Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function, Ann Thorac Surg., 71, 1428, 10.1016/S0003-4975(01)02486-9 Levin, 2009, Early on–cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome, Circulation., 120, 1664, 10.1161/CIRCULATIONAHA.108.814533 Sun, 2008, Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?, Eur J Cardiothorac Surg., 34, 820, 10.1016/j.ejcts.2008.07.012 Egi, 2007, Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: A systematic literature review, Ann Thorac Surg., 83, 715, 10.1016/j.athoracsur.2006.08.041 Hosseinian, 2016, Magic bullet for vasoplegia?, Anesth Analg., 122, 194, 10.1213/ANE.0000000000001045 Gamper, 2016, Cochrane Database Syst Rev [Internet]. Morozowich, 2015, Pharmacologic agents for acute hemodynamic instability: Recent advances in the management of perioperative shock- A systematic review, Ann Card Anaesth., 18, 543, 10.4103/0971-9784.166464 Beurton, 2016, Beneficial effects of norepinephrine alone on cardiovascular function and tissue oxygenation in a pig model of cardiogenic shock: SHOCK., 46, 214 Russell, 2013, Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock, Am J Respir Crit Care Med., 188, 356, 10.1164/rccm.201302-0355OC Landry, 2001, The pathogenesis of vasodilatory shock, N Engl J Med., 345, 588, 10.1056/NEJMra002709 Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E. Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg. [Internet]. [consultado 7 Ene 2019]. Disponible en: https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/1749-8090-5-17. Levy, 2018, Vasoplegia treatments: The past, the present, and the future, Crit Care [Internet]., 22 Oz, 2011, Cellular and molecular actions of methylene blue in the nervous system, Med Res Rev., 31, 93, 10.1002/med.20177 Schirmer, 2011, Lest we forget you – methylene blue…, Neurobiol Aging., 32, 10.1016/j.neurobiolaging.2010.12.012 Drugbank. Methylene blue. [Internet] [consultado 25 Abr 2019]. Disponible en: https://www.drugbank.ca/drugs/DB09241. FDA Approved Drug Products. Methylene blue. [Internet] [consultado 2 Abr 2019]. Disponible en: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Lenglet, 2011, Methylene blue: Potential use of an antique molecule in vasoplegic syndrome during cardiac surgery, Expert Rev Cardiovasc Ther., 9, 1519, 10.1586/erc.11.160 Evora, 2006, The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target, Curr Drug Targets., 7, 1195, 10.2174/138945006778226679 Mayer, 1993, Inhibition of nitric oxide synthesis by methylene blue, Biochem Pharmacol., 45, 367, 10.1016/0006-2952(93)90072-5 Hosseinian, 2016, Methylene blue: Magic bullet for vasoplegia?, Anesth Analg., 122, 194, 10.1213/ANE.0000000000001045 Bardakci, 2006, Methylene blue decreases ischemia-reperfusion (I/R)-induced spinal cord injury: An in vivo study in an I/R rabbit model, Eur Surg Res., 38, 482, 10.1159/000096007 Stawicki, 2008, Methylene blue and vasoplegia: Who, when, and how?, Mini-Rev Med Chem., 8, 472, 10.2174/138955708784223477 Clifton, 2003, Methylene blue, Am J Ther, 10, 289, 10.1097/00045391-200307000-00009 Shanmugam, 2005, Vasoplegic syndrome: The role of methylene blue, Eur J Cardiothorac Surg., 28, 705, 10.1016/j.ejcts.2005.07.011 Peter, 2000, Pharmacokinetics and organ distribution of intravenous and oral methylene blue, Eur J Clin Pharmacol., 56, 247, 10.1007/s002280000124 FDA. Methylene blue, prescribing information, PROVAYBLUETM injection. U.S. Approval: 2016 [Internet] [consultado 5 Mar 2019]. Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204630s000lbl.pdf. Evora, 2014, Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised, Rev Bras Cir Cardiovasc [Internet]., 10.5935/1678-9741.20140115 Levin, 2004, Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery, Ann Thorac Surg., 77, 496, 10.1016/S0003-4975(03)01510-8 Leyh RG, Kofidis T, Struber M, Fischer S, Knobloch K, Waschmann B, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2003 Jun 1;125(6):1426-31. Weiner, 2013, Methylene blue is associated with poor outcomes in vasoplegic shock, J Cardiothorac Vasc Anesth., 27, 1233, 10.1053/j.jvca.2013.02.026 Lexicomp Online. Methylene blue. Drug information. [Internet] [consultado 1 Jun 2019]. Disponible en: https://www-uptodate-com.ez.unisabana.edu.co/contents/methylene-blue-drug-information?search=AZUL%20DE%20METILENO&source=panel_search_result&https://www-uptodate-com.ez.unisabana.edu.co/contents/methylene-blue-drug-information?search=AZUL%20DE%20METILENO&source=panel_search_result&selectedTitle=1∼148&usage_type=panel&kp_tab=drug_general&display_rank=1#F46732338. Özal, 2005, Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery, Ann Thorac Surg., 79, 1615, 10.1016/j.athoracsur.2004.10.038 Dewachter, 2005, Severe anaphylactic shock with methylene blue instillation, Anesth Analg., 101, 149, 10.1213/01.ANE.0000153497.60047.80 Foltz, 2006, Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine, Am J Hematol., 81, 210, 10.1002/ajh.20547 Sweet, 2007, Methylene-blue: Associated encephalopathy, J Am Coll Surg, 204, 454, 10.1016/j.jamcollsurg.2006.12.030 McRobb, 2008, Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review, JECT., 40, 206, 10.1051/ject/200840206 Kirlangitis, 1990, False indication of arterial oxygen desaturation and methemoglobinemia following injection of methylene blue in urological surgery, Mil Med., 155, 260, 10.1093/milmed/155.6.260 Mittnacht, 2007, Methylene blue administration is associated with decreased cerebral oximetry values, Anesth Analg., 105, 549, 10.1213/01.ane.0000265695.72785.9d Wolvetang, 2016, Serotonin syndrome after methylene blue administration during cardiac surgery: A case report and review, J Cardiothorac Vasc Anesth., 30, 1042, 10.1053/j.jvca.2015.11.019 Smith, 2015, Serotonin syndrome following methylene blue administration during cardiothoracic surgery, J Pharm Pract., 28, 207, 10.1177/0897190014568389 Shanmugam, 2008, Serotonin syndrome following cardiac surgery, Interact Cardiovasc Thorac Surg., 7, 656, 10.1510/icvts.2007.173104 FDA Drug Safety Communication: Updated information about the drug interaction between methylene blue (methylthioninium chloride) and serotonergic psychiatric medications. [Internet] [consultado 30 Abr 2019]. Disponible en: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-drug-interaction-between-methylene-blue. Kofidis, 2001, Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation, J Thorac Cardiovasc Surg., 122, 823, 10.1067/mtc.2001.115153 Yiu, 1999, Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery, J Thorac Cardiovasc Surg., 118, 195, 10.1016/S0022-5223(99)70161-3 Manghelli, 2015, A reminder of methylene blue's effectiveness in treating vasoplegic syndrome after on-pump cardiac surgery, Tex Heart Inst J., 42, 491, 10.14503/THIJ-14-4470 Maslow, 2006, The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass, Anesth Analg., 103, 2, 10.1213/01.ane.0000221261.25310.fe Levin, 2001, Síndrome vasopléjico en posoperatorio de cirugía cardíaca. Reducción de la mortalidad mediante el empleo de azul de metileno, Rev Argent Cardiol., 69, 6 Mehaffey, 2017, Methylene blue for vasoplegic syndrome after cardiac operation: Early administration improves survival, Ann Thorac Surg., 104, 36, 10.1016/j.athoracsur.2017.02.057 Pasin, 2013, Methylene blue as a vasopressor: A meta-analysis of randomised trials, Crit Care Resusc J Australas Acad Crit Care Med., 15, 42 Belletti, 2015, Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials, PLOS ONE., 10, e0142605, 10.1371/journal.pone.0142605 Mazzeffi, 2017, Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study, Ann Card Anaesth., 20, 178, 10.4103/aca.ACA_237_16 Habib, 2018, Methylene blue for vasoplegic syndrome postcardiac surgery, Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med., 22, 168